GHSR1α is ubiquitously expressed throughout the gut–brain axis, including in the NTS and thalamic paraventricular nucleus, and represents a major therapeutic target for several disorders, including obesity, diabetes, anxiety, and depression. Here, GHSR is linked to obesity disorder.